BridgeBio Pharma Inc. (BBIO)
35.14
-0.46 (-1.31%)
At close: Jan 15, 2025, 11:53 AM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Net Income | -643.20M | -484.65M | -586.45M | -505.49M | -288.58M | -169.45M | -43.83M |
| Depreciation & Amortization | 6.49M | 6.77M | 5.84M | 3.09M | 859.00K | 245.00K | 260.00K |
| Stock-Based Compensation | n/a | 91.56M | 99.50M | 58.46M | 21.37M | 6.07M | 1.84M |
| Other Working Capital | -13.05M | 28.43M | -7.23M | 15.67M | -6.26M | 5.79M | -334.00K |
| Other Non-Cash Items | 103.93M | -61.25M | 18.50M | 31.16M | 24.54M | 18.89M | 260.00K |
| Deferred Income Tax | n/a | n/a | -30.93M | -1.87M | -859.00K | -14.89M | -260.00K |
| Change in Working Capital | 5.06M | 28.08M | -4.40M | 14.93M | -10.91M | 22.49M | 1.24M |
| Operating Cash Flow | -527.72M | -419.49M | -497.93M | -399.71M | -253.59M | -136.64M | -40.49M |
| Capital Expenditures | -1.31M | -6.32M | -48.25M | -7.52M | -5.14M | -18.18M | -464.00K |
| Acquisitions | n/a | 120.00M | -35.00M | 21.24M | -5.49M | -2.86M | 2.84M |
| Purchase of Investments | -137.26M | -193.06M | -643.27M | -287.85M | -212.90M | n/a | n/a |
| Sales Maturities Of Investments | 193.11M | 532.52M | 477.04M | 242.23M | 5.49M | n/a | n/a |
| Other Investing Acitivies | -503.00K | 120.00M | 48.65M | -21.09M | 784.00K | -2.86M | n/a |
| Investing Cash Flow | 54.03M | 453.15M | -200.83M | -52.99M | -217.25M | -21.04M | -464.00K |
| Debt Repayment | n/a | -20.49M | 1.08B | 550.00M | 36.94M | 56.38M | 4.13M |
| Common Stock Repurchased | -6.88M | -1.56M | -204.75M | -75.71M | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | -997.00K | n/a | -1.15M |
| Other Financial Acitivies | 8.61M | 4.06M | -138.49M | -27.10M | -4.38M | 349.63M | 108.85M |
| Financial Cash Flow | 451.54M | -13.13M | 736.45M | 447.19M | 398.79M | 501.55M | 112.98M |
| Net Cash Flow | -22.15M | 20.52M | 37.69M | -5.52M | -72.05M | 343.87M | 72.03M |
| Free Cash Flow | -529.03M | -425.81M | -546.18M | -407.23M | -258.73M | -154.82M | -40.95M |